Orchestra BioMed Showcases AVIM Therapy and Virtue SAB at ICI Meeting
I'm PortAI, I can summarize articles.
Orchestra BioMed Holdings Inc. showcased its AVIM Therapy and Virtue SAB at the 2025 Innovation in Cardiology Intervention meeting in Tel Aviv. The company presented on its collaboration with Medtronic for hypertension treatment in pacemaker patients and highlighted the Virtue SAB's drug delivery technology for coronary artery disease. The news was originally published by Orchestra Biomed via GlobeNewswire.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments